Table 2.
Control | ERD | NERD | AEE | ||||
---|---|---|---|---|---|---|---|
|
|
|
|||||
OR (95% CI) | P-value | OR (95% CI) | P-value | OR (95% CI) | P-value | ||
Age | 1.00 | 1.01 (0.99–1.02) | 0.495 | 1.00 (0.99–1.00) | 0.157 | 1.00 (1.00–1.01) | 0.524 |
Sex (female) | 1.00 | 0.68 (0.39–1.18) | 0.168 | 1.42 (1.20–1.69) | < 0.001 | 0.38 (0.31–0.48) | < 0.001 |
BMI | 1.00 | 1.18 (1.13–1.24) | < 0.001 | 1.04 (1.02–1.06) | < 0.001 | 1.12 (1.09–1.14) | < 0.001 |
Current smoking | 1.00 | 2.28 (1.47–3.55) | < 0.001 | 1.37 (1.18–1.59) | < 0.001 | 1.46 (1.26–1.70) | < 0.001 |
Alcohol use | 1.00 | 1.44 (0.88–2.34) | 0.144 | 0.96 (0.83–1.10) | 0.531 | 1.25 (1.05–1.49) | 0.012 |
Marriage status | 1.00 | 0.45 (0.27–0.74) | 0.002 | 0.71 (0.58–0.87) | < 0.001 | 0.96 (0.76–1.22) | 0.728 |
Diabetes mellitus | 1.00 | 0.51 (0.22–1.18) | 0.116 | 0.65 (0.48–0.87) | 0.004 | 1.13 (0.91–1.41) | 0.269 |
Aspirin use | 1.00 | 0.80 (0.43–1.49) | 0.480 | 1.00 (0.80–1.25) | 0.993 | 1.11 (0.91–1.36) | 0.310 |
NSAID use | 1.00 | 0.59 (0.25–1.40) | 0.230 | 1.19 (0.92–1.53) | 0.180 | 0.93 (0.73–1.19) | 0.567 |
Helicobacter pylori seropositivity | 1.00 | 0.32 (0.23–0.46) | < 0.001 | 0.96 (0.86–1.08) | 0.540 | 0.36 (0.31–0.40) | < 0.001 |
Atrophic gastritis | 1.00 | 0.55 (0.35–0.87) | 0.010 | 0.88 (0.76–1.02) | 0.084 | 0.80 (0.69–0.93) | 0.003 |
Intestinal metaplasia | 1.00 | 1.10 (0.58–2.11) | 0.763 | 0.79 (0.64–0.99) | 0.038 | 0.84 (0.67–1.06) | 0.147 |
State anxiety | 1.00 | 2.20 (1.27–3.81) | 0.005 | 1.89 (1.53–2.33) | < 0.001 | 1.25 (0.96–1.65) | 0.103 |
Trait anxiety | 1.00 | 1.07 (0.44–2.59) | 0.882 | 1.78 (1.34–2.35) | < 0.001 | 1.27 (0.83–1.96) | 0.270 |
Depression | 1.00 | 2.23 (1.18–4.22) | 0.013 | 2.21 (1.75–2.80) | < 0.001 | 1.29 (0.93–1.80) | 0.132 |
ERD, erosive reflux disease; NERD, non-erosive reflux disease; AEE, asymptomatic erosive esophagitis; BMI, body mass index.